These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 26088547)

  • 21. Combination therapy with polymyxin B for the treatment of multidrug-resistant Gram-negative respiratory tract infections.
    Sobieszczyk ME; Furuya EY; Hay CM; Pancholi P; Della-Latta P; Hammer SM; Kubin CJ
    J Antimicrob Chemother; 2004 Aug; 54(2):566-9. PubMed ID: 15269195
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An audit of colistin use in neonatal sepsis from a tertiary care centre of a resource-limited country.
    Jasani B; Kannan S; Nanavati R; Gogtay NJ; Thatte U
    Indian J Med Res; 2016 Sep; 144(3):433-439. PubMed ID: 28139542
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacokinetics of intravenous polymyxin B in critically ill patients.
    Zavascki AP; Goldani LZ; Cao G; Superti SV; Lutz L; Barth AL; Ramos F; Boniatti MM; Nation RL; Li J
    Clin Infect Dis; 2008 Nov; 47(10):1298-304. PubMed ID: 18840079
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The ability of endotoxin adsorption during a longer duration of direct hemoperfusion with a polymyxin B-immobilized fiber column in patients with septic shock.
    Shimizu T; Obata T; Sonoda H; Akabori H; Tabata T; Eguchi Y; Endo Y; Tani T
    Transfus Apher Sci; 2013 Dec; 49(3):499-503. PubMed ID: 23683501
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tackling antimicrobial resistance in neonatal sepsis.
    Folgori L; Ellis SJ; Bielicki JA; Heath PT; Sharland M; Balasegaram M
    Lancet Glob Health; 2017 Nov; 5(11):e1066-e1068. PubMed ID: 29025624
    [No Abstract]   [Full Text] [Related]  

  • 26. Medication Therapy for Early-Onset Neonatal Sepsis.
    Moffett SM; Kitts HL; Henderson SJ
    AACN Adv Crit Care; 2016 Jul; 27(3):253-258. PubMed ID: 27959305
    [No Abstract]   [Full Text] [Related]  

  • 27. Population pharmacokinetics of intravenous polymyxin B in critically ill patients: implications for selection of dosage regimens.
    Sandri AM; Landersdorfer CB; Jacob J; Boniatti MM; Dalarosa MG; Falci DR; Behle TF; Bordinhão RC; Wang J; Forrest A; Nation RL; Li J; Zavascki AP
    Clin Infect Dis; 2013 Aug; 57(4):524-31. PubMed ID: 23697744
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Parenteral polymyxin B use in patients with multidrug-resistant gram-negative bacteremia and urinary tract infections: a retrospective case series.
    Pastewski AA; Caruso P; Parris AR; Dizon R; Kopec R; Sharma S; Mayer S; Ghitan M; Chapnick EK
    Ann Pharmacother; 2008 Sep; 42(9):1177-87. PubMed ID: 18664609
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Postoperative polymyxin B hemoperfusion and mortality in patients with abdominal septic shock: a propensity-matched analysis.
    Iwagami M; Yasunaga H; Doi K; Horiguchi H; Fushimi K; Matsubara T; Yahagi N; Noiri E
    Crit Care Med; 2014 May; 42(5):1187-93. PubMed ID: 24365858
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Risk factors for nephrotoxicity onset associated with polymyxin B therapy.
    Dubrovskaya Y; Prasad N; Lee Y; Esaian D; Figueroa DA; Tam VH
    J Antimicrob Chemother; 2015; 70(6):1903-7. PubMed ID: 25652747
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neonates, Sepsis, and Antimicrobial Resistance-Steps to Tackle Difficult Issues in Our Most Vulnerable Population.
    Guitart C; Peters A; Lotfinejad N; Pittet D
    J Obstet Gynaecol Can; 2021 Apr; 43(4):425-426. PubMed ID: 32622545
    [No Abstract]   [Full Text] [Related]  

  • 32. [Dark grey hyperpigmentation on the face and neck. Diagnose: Minocycline-induced hyperpigmentation type III].
    Wienrich BG; Bertsch HP; Schön MP; Emmert S
    J Dtsch Dermatol Ges; 2010 Jul; 8(7):544-6. PubMed ID: 20642719
    [No Abstract]   [Full Text] [Related]  

  • 33. Hemoperfusion with polymyxin B-immobilized fiber reduces urinary podocyte numbers in patients with severe sepsis.
    Shimada N; Nakamura T; Shoji H; Hara M; Ebihara I; Koide H
    Nephron; 2000 Aug; 85(4):364-5. PubMed ID: 10940754
    [No Abstract]   [Full Text] [Related]  

  • 34. Septic neonate rescued by polymyxin B hemoperfusion.
    Hirakawa E; Ibara S; Tokuhisa T; Hiwatashi S; Hayashida Y; Maede Y; Matsui T; Nakazawa Y; Inoue T; Kodaira Y
    Pediatr Int; 2013 Jun; 55(3):e70-2. PubMed ID: 23782384
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Spurious bruising in a patient taking warfarin: minocycline-induced skin hyperpigmentation.
    Huq F; Durso SC
    J Am Geriatr Soc; 2008 Jun; 56(6):1156-7. PubMed ID: 18554371
    [No Abstract]   [Full Text] [Related]  

  • 36. Intraventricular polymyxin B for the treatment of neonatal meningo-ventriculitis caused by multi-resistant Acinetobacter baumannii--case report and review of literature.
    Piparsania S; Rajput N; Bhatambare G
    Turk J Pediatr; 2012; 54(5):548-54. PubMed ID: 23427525
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Polymyxin B and haemofiltration in an adolescent with leukaemia.
    Baird JS
    J Antimicrob Chemother; 2014 May; 69(5):1434. PubMed ID: 24402503
    [No Abstract]   [Full Text] [Related]  

  • 38. Early-onset neonatal sepsis caused by
    Narayanan N; Williams RL; Turner PC; Paul SP
    Br J Hosp Med (Lond); 2020 Jan; 81(1):1-2. PubMed ID: 32003623
    [No Abstract]   [Full Text] [Related]  

  • 39. What's your assessment? Drug-induced pigmentation.
    Petros HM
    Dermatol Nurs; 2009; 21(6):327-8, 335. PubMed ID: 20102016
    [No Abstract]   [Full Text] [Related]  

  • 40. Management of sepsis during MARS treatment in acute on chronic liver failure.
    Novelli G; Morabito V; Pugliese F; Ferretti G; Novelli S; Ianni S; Lai Q; Rossi M; Berloco PB
    Transplant Proc; 2011 May; 43(4):1085-90. PubMed ID: 21620059
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.